Back to search
T-cell NHL (PTCL or CTCL)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which T-cell NHL (PTCL or CTCL) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which T-cell NHL (PTCL or CTCL) trials you may qualify forBackground: Chemokine receptor 4 (CCR4) is a protein that is found on the surface of certain T-cell lymphoma cells and is common in mature T-cell cancers. Whit…
This is a multi-center, open-label, non-randomized, single-arm clinical trial. Refractory/relapse T-NHL patients are treated with autologous and allogeneic CD5…
This is a multi-center, open-label, non-randomized, single-arm clinical trial. Refractory/relapse T-NHL patients are treated with autologous and allogeneic CD7…
The purpose of this study is to determine the safety, tolerability, PK and pharmacodynamics of KK2223 in adult participants with relapsed or refractory peripher…
This phase I trial studies the side effects and best dose of anti-inducible T-cell co-stimulator (ICOS) monoclonal antibody MEDI-570 in treating patients with p…